Targeting the Serotonin (5-HT) 5-Ht2c Receptor: Rational Design of Small Molecule Allosteric Modulators to Treat Psychostimulant Use Disorders

Christopher Wild,Chunyong Ding,Gongliang Zhang,Noelle Anastasio,J. Scott Moncrief,Theresa Carbonaro,Robert Fox,Sonja Stutz,Rachel Hartley,Thressa Smith,Kathryn Cunningham,Jia Zhou
DOI: https://doi.org/10.1016/j.drugalcdep.2014.09.742
IF: 4.852
2015-01-01
Drug and Alcohol Dependence
Abstract:5-Aminolaevulinic acid (ALA) prodrugs have been widely used in photodynamic therapy (PDT) as precursors to the natural photosensitizer, protoporphyrin IX (PpIX). The main disadvantage of this therapy is that ALA is poorly absorbed by cells due to its high hydrophilicity. In order to improve the therapeutical effect and induce higher yields of PpIX, a range of prodrugs of ALA conjugated to 3-hydroxypyridin-4-ones (HPO) were synthesized. Pharmacokinetic studies indicated that some of the ALA–HPO conjugates are more efficient than ALA for PpIX production in the human breast adenocarcinoma cell line (MDA-MB-468). The intracellular porphyrin fluorescence levels showed good correlation with cellular phototoxicity following light exposure, suggesting the potential application of the ALA–HPO conjugates in photodynamic therapy.
What problem does this paper attempt to address?